Skip to content

Clinical trials

Phase 1 Leukemia, Myelomonocytic, Chronic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Phase: Phase 1 Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20161
20171
20181
20191
20202
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
AbbVie1
Bayer1
Boehringer Ingelheim1
Eli Lilly and Company1
Hemavant Sciences GmbH1
Janssen Research & Development, LLC1
Pfizer1
Prelude Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic10
Myelodysplastic Syndromes9
Leukemia, Myeloid, Acute7
Leukemia2
Myeloproliferative Disorders2
Bone Marrow Diseases1
Hematologic Diseases1
Hematologic Neoplasms1
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myeloid1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.